Randomized trial · people

TB-500 on venous ulcers: safety comparable to placebo in Phase 2

Checked against the paper Randomized trialPublished by PepVault

The takeaway

An early human trial found thymosin beta 4 on venous ulcers had safety comparable to placebo, with early signs that the 0.03% dose might speed healing.

Kind
Randomized trial
Studied in
People
Number studied
73
Published
2010
Journal
Ann N Y Acad Sci

What they tested

The team tested whether thymosin beta 4 put on the skin is safe, well tolerated and helpful for healing venous ulcers, which are long-lasting sores of the lower legs.

How the study was done

A double-blind, placebo-controlled, dose-escalation Phase 2 trial randomized 73 patients with venous stasis ulcers at European sites in Italy and Poland. Double-blind means neither patients nor staff knew who got the peptide, and placebo is a dummy treatment.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At every dose tested, the safety of thymosin beta 4 was judged acceptable and similar to placebo. The results pointed to the 0.03% dose as possibly speeding wound healing. About 25% of patients had their wounds close fully within 3 months, mainly when the wounds were of small or medium size, or of mild or moderate severity.

What it doesn’t show

This was a small, early-stage trial, and its signs of faster healing were preliminary, not a firm result. It tested the peptide applied to the skin of venous ulcers only, so it says nothing about other uses or other ways of giving it.

The paper

Guarnera et al. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci. 2010.

The compound

More studies on TB-500

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo